📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Salivary Gland Infection Companies

Salivary gland infections, also known as sialadenitis, can be caused by bacterial or viral infections leading to inflammation of the salivary glands. The treatment typically involves antibiotics or antiviral medications depending on the cause. While there may not be specific companies exclusively focused on salivary gland infections, pharmaceutical companies that develop antibiotics and antiviral medications may have products relevant to the treatment of such infections.

Salivary Gland Infection Key Companies


Latest Salivary Gland Infection Companies Update

Novartis receives Phase 3 trial success for Ilaris (canakinumab) in treating Sjogren's syndrome, a chronic autoimmune disease affecting salivary glands. This positive outcome could pave the way for expanded treatment options for patients with this condition.

Medtronic introduces the SialoCath™ System in Japan, a minimally invasive catheter system for treating sialadenitis, expanding its reach in the Asia-Pacific market.

St. Jude Medical releases its Parotid Mucosa Excision System (ParoMEX®) in South Korea, offering a minimally invasive option for managing chronic sialadenitis in parotid glands.

Olympus Corporation launches its new sialendoscopy system in China, providing improved visualization and access for minimally invasive salivary gland procedures.

Stryker Corporation partners with Auris Medical to develop and commercialize novel salivary gland infection treatment options, combining their expertise in medical devices and biopharmaceuticals.

List of Salivary Gland Infection Key Companies in the Market

  • AbbVie Inc. (US)

  • Allergan (Republic of Ireland)

  • AstraZeneca (UK)

  • FUJIFILM Holdings Corporation (Japan)

  • General Electric Company (US)

  • GlaxoSmithKline plc. (UK)

  • Johnson & Johnson Services Inc. (US)

  • Merck & Co.Inc. (US)

  • Pfizer Inc.(US)

  • Siemens Healthcare GmbH (Germany)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.